SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+10.46%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$223M
AUM Growth
+$223M
(-16%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-28.85%
Top 10 Holdings %
Top 10 Hldgs %
67.81%
Holding
57
New
8
Increased
3
Reduced
13
Closed
16
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$24.3M |
| 2 |
Maximus
MMS
|
$14.5M |
| 3 |
Annexon
ANNX
|
$8.48M |
| 4 |
Relay Therapeutics
RLAY
|
$6.7M |
| 5 |
CMPS
Compass Pathways
CMPS
|
$3.91M |
Top Sells
| 1 |
Teleflex
TFX
|
$17.8M |
| 2 |
Labcorp
LH
|
$16.2M |
| 3 |
Smith & Nephew
SNN
|
$14.4M |
| 4 |
Organon & Co
OGN
|
$12.6M |
| 5 |
GSK
GSK
|
$12M |
Sector Composition
| 1 | Healthcare | 88.55% |
| 2 | Industrials | 6.48% |
| 3 | Consumer Staples | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prelude Therapeutics
PRLD
$68.5M
| – | – |
-320,394
| Closed | -$1.22M |
|
|
52
Smith & Nephew
SNN
$16.3B
| – | – |
-579,619
| Closed | -$14.4M |
|
53
ARS Pharmaceuticals
SPRY
$1.15B
| – | – |
-217,864
| Closed | -$1.85M |
|
54
Stoke Therapeutics
STOK
$1.08B
| – | – |
-175,301
| Closed | -$2.37M |
|
|
THRD
55
DELISTED
Third Harmonic Bio
THRD
| – | – |
-163,363
| Closed | -$2.12M |
|
56
Zymeworks
ZYME
$1.12B
| – | – |
-491,128
| Closed | -$4.18M |
|
|
ASLN
57
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| – | – |
-254,150
| Closed | -$76.2K |
|